Trial · NCT06302998
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | in-hospital mortality | throughout the hospitalization period on average 90 days. | All-cause inhospital mortality as a binary outcome |
| Secondary | survival analysis | through out the hospitalization period or 28 days after inclusion if discharged from hosptia; before 28 days | time to die using Kaplan Mier Curve |
| Secondary | Norepinephrine Equivalent Dose (NED) | over the first three days after enrolment or death | mean NED over the first three days after enrolment or death, whichever comes first; the NED of epinephrine will be estimated as a 1:1 ratio |
| Secondary | Duration of vasopressor infusion in survivors | through out the hospitalization period or 28 days after inclusion if discharged from hosptial before 28 days | Duration in hours from the start of the vasopressor (NE or vasopressin) infusion till the time of discontinuation. |
| Secondary | Initiation of invasive mechanical ventilation (IMV) | through out the hospitalization period or 28 days after inclusion if discharged from hosptial before 28 days | incidence of IMV |
| Secondary | Duration of IMV | through out the hospitalization period or 28 days after inclusion if discharged from hosptial before 28 days | duratioin in hours |
| Secondary | Early acute kidney injury (AKI) | within 48 hours | AKI according to the KDIGO guidelines 2012 |
| Secondary | Late acute kidney injury (AKI) | between 48 hours and 7 days | AKI according to the KDIGO guidelines 2012 |
| Secondary | Acute Physiology and Chronic Health Evaluation (APACHE-II) | on the 3rd day after enrollment | As a score on MedCalc |
| Secondary | Simplified Acute Physiology Score (SAPS) II score | on the 3rd day after enrollment | As a score on MedCalc |
| Secondary | ICU length of stay | during hospitalization period on average 90 days | duration in days in survivors |
| Secondary | Hospital length of stay | during hospitlaization period on average 90 days | duration in days in survivors |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06302998/registered